Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 2/20 | 0.35 |
| ▸ | GNAO1 | P09471 | 2/20 | 0.35 |
| ▸ | GNAI1 | P63096 | 2/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.34 |
| ▸ | CXCR4 | P61073 | 8/20 | 0.34 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.33 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.32 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8852097 | 0.96 | GNAI3 (0.39) | GNAI3GNAO1GNAI1SIGMAR1CXCR4 | |
| SCHEMBL8851872 | 0.87 | CARM1 (0.33) | — | |
| SCHEMBL7013588 | 0.84 | — | — | |
| SCHEMBL7966483 | 0.81 | GNAI3 (0.48) | GNAI3GNAO1GNAI1SIGMAR1GRIN2B | |
| SCHEMBL8852122 | 0.80 | SAT1 (0.46) | GNAI3GNAO1GNAI1CXCR4CXCL12 | |
| SCHEMBL9432411 | 0.79 | GNAI3 (0.56) | GNAI3GNAO1GNAI1EPHX1 | |
| SCHEMBL8850999 | 0.79 | CXCR4 (0.34) | GNAI3GNAO1GNAI1CXCR4CXCL12 | |
| SCHEMBL681346 | 0.78 | CXCR4 (0.52) | SIGMAR1CXCR4CXCL12KDM4E | |
| SCHEMBL8111938 | 0.78 | GNAI3 (0.59) | GNAI3GNAO1GNAI1EPHX1 | |
| SCHEMBL8851126 | 0.77 | SMYD3 (0.39) | GNAI3GNAO1GNAI1SIGMAR1CXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5618814-A | Trisubstituted pyrimido [5,4-d] pyrimidines for modulating multi-drug resistance and pharmaceutical compositions containing these compounds | DR. KARL THOMAE GMBH (DE) | 1997-04-08 | — | — | US | disclosed |
| EP-0645390-A1 | Trisubstituted pyrimido 5,4-d pyrimidines for modulating multidrug resistance, drugs containing these compounds and processes for their preparation | Dr. Karl Thomae GmbH (DE) | 1995-03-29 | — | — | EP | disclosed |